In particular, after TAC/MSCH (100 mg/kg TAC/13 μg/kg MSC) administration, the phosphorylation of GSK3β and AKT was remarkably increased compared to that in the TAC-H group, which proves that MSC can promote the TAC effect on improving insulin resistance (Figure 12). The gene discussed is GSK3B; the disease is persistent truncus arteriosus.